Clinical Research, Pharma & Healthcare FinancingCelltrion’s Remdantry™ to launch in Canada on April 1, 2025Business WireMarch 27, 2025March 28, 2025 by Business WireMarch 27, 2025March 28, 2025017 Celltrion, Inc., a leading global biopharmaceutical company, announced that Remdantry™ will be available in Canada as of April 1, 2025. Remdantry™, previously known as Inflectra®,...